Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Today in Medicine.
Governor Ivey Announces Medicaid Commissioner Stephanie Azar to Chair State Employees’ Insurance Board, Appoints Bo Offord as Agency Commissioner
Office of Alabama Governor
·
July 10, 2025
MONTGOMERY – Governor Kay Ivey on Thursday announced she will appoint Bo Offord to serve as commissioner of the Alabama Medicaid Agency. Stephanie McGee Azar, after leading the Medicaid Agency for over 13 years, will become the chief executive...
Acumen Pharmaceuticals to Present Studies on Cost Savings Associated with Use of pTau217 Screening Assay in Phase 2 ALTITUDE-AD Study and Sabirnetug Oligomer-Selectivity at the Alzheimer’s Association International Conference (AAIC®) 2025
GlobeNewswire, Inc.
·
July 10, 2025
NEWTON, Mass., July 10, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of...
Amplity Rebrand Recognized: A New Approach To Pharma Outsourcing Services
EIN Presswire
·
July 10, 2025
LANGHORNE, PA, UNITED STATES, July 10, 2025 /EINPresswire.com/ -- Amplity, a full-service partner for outsourcing flexible medical and commercial services, is honored to be named a Titan and GDUSA awardee for its comprehensive rebrand work...
Cocrystal Pharma to Present Data from Phase 1 Study of First-in-Class Norovirus Protease Inhibitor CDI-988 at the 9th International Calicivirus Conference
GlobeNewswire, Inc.
·
July 10, 2025
BOTHELL, Wash., July 10, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that its first-in-class pan-viral protease inhibitor CDI-988 has been selected for an oral presentation at the 9th International Calicivirus...
RCKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire, Inc.
·
July 10, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Rocket Pharmaceuticals, Inc. (“Rocket” or...
SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire, Inc.
·
July 10, 2025
DENVER, July 10, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life,...
Green Building Materials Market: Innovations and Future Growth in Sustainable Construction | DataMIntelligence
EIN Presswire
·
July 22, 2025
Projected at 7.5% CAGR,the green building materials market will hit $490.72Bn by 2032, fueled by sustainability rules,tech innovation & eco-conscious building. NEW YORK, NY, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- Market Overview :-...
Rhythm Pharmaceuticals, Inc. Announces Pricing of Upsized Public Offering of Common Stock
GlobeNewswire, Inc.
·
July 10, 2025
BOSTON, July 10, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (“Rhythm”), a global, commercial-stage biopharmaceutical company dedicated to transforming the lives of patients living with rare neuroendocrine diseases, today...
Intelligent Bio Solutions to Present PK Study Data at Association for Diagnostics and Laboratory Medicine 2025 Clinical Lab Expo
GlobeNewswire, Inc.
·
July 10, 2025
Data shows excretion of codeine in fingerprint sweat INBS’ System is viable option for non-invasive diagnostic testing NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical...
IBCCES Certifies Surprise Fire-Medical Department as a Certified Autism Center™, Enhances Community Support
EIN Presswire
·
July 10, 2025
SURPRISE, AZ, UNITED STATES, July 10, 2025 /EINPresswire.com/ -- The International Board of Credentialing and Continuing Education Standards (IBCCES) awards the Certified Autism Center™ (CAC) to the Surprise Fire-Medical Department. To earn this...
9 Medicaid Providers Indicted on Fraud Charges
Ohio Attorney General
·
July 10, 2025
(COLUMBUS, Ohio) — In indictments filed this week by the office of Ohio Attorney General Dave Yost, nine Medicaid providers are accused of stealing a combined $1.2 million from the government health-care program for the needy. Eight home-health...
Don Allen of Columbia Counseling Consulting and Research LLC Recently Featured on Close Up Radio
EIN Presswire
·
July 22, 2025
AUSTIN, TX, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- Columbus, OH / Austin, TX – When we first fall in love everything can feel exciting and new; almost like: ‘The birds are singing, and we are floating on cloud nine’. It’s easy to...
Important Notice to Long-Term Shareholders of Methode Electronics, Inc. (NYSE: MEI); Manhattan Associates, Inc. (NASDAQ: MANH); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI); Grabar Law Office is…
GlobeNewswire, Inc.
·
July 10, 2025
PHILADELPHIA, July 10, 2025 (GLOBE NEWSWIRE) -- Methode Electronics, Inc. (NYSE: MEI): Current Methode Electronics, Inc. (NYSE: MEI) shareholders who have held Methode Electronics shares since prior to June 23, 2022, can seek corporate reforms,...
Closed Suction Catheter Recall: Avanos Medical, Inc. Removes Ballard Closed Suction Systems Due to Risk of Non-Sterility
U.S. Food and Drug Administration
·
July 10, 2025
This recall involves updating instructions for using devices and does not involve removing them from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you...
Tonix Pharmaceuticals Announces Presentation of New Data on Mpox and Smallpox Vaccine Candidate TNX-801 at the Vaccine Congress 2025
GlobeNewswire, Inc.
·
July 10, 2025
TNX-801 is up to 100,000-fold less virulent than live smallpox vaccine strains and a single dose provides robust immunogenicity and protection against mpox and rabbitpox (more than one year) in animals Subcutaneous administration of TNX-801...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT
GlobeNewswire, Inc.
·
July 10, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ: RCKT). Such investors are advised to contact Danielle Peyton...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quipt Home Medical Corp. - QIPT
GlobeNewswire, Inc.
·
July 10, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ: QIPT). Such investors are advised to contact Danielle Peyton at...
Merck Reveals Acquiring UK’s Verona Pharma
MENAFN
·
July 10, 2025
(MENAFN) Merck, a German drugmaker, revealed on Wednesday that it has finalized a deal to purchase the UK-headquartered Verona Pharma for $10 billion, or $107 per share. This strategic acquisition is aimed at enhancing Merck’s range of treatments...
OSS Announces $2 Million Follow-On Production Order from Innovative Medical Imaging OEM
GlobeNewswire, Inc.
·
July 10, 2025
ESCONDIDO, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. (OSS or the Company) (Nasdaq: OSS), a leader in rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML) and sensor processing at the edge,...
German Merck Seals USD10B Deal to Purchase UK’s Verona Pharma
MENAFN
·
July 10, 2025
(MENAFN) German pharmaceutical giant Merck revealed on Wednesday that it has finalized a $10 billion agreement to purchase UK-based Verona Pharma at $107 per share. This strategic move aims to broaden Merck’s portfolio of treatments targeting...